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In this report, we describe a High-Throughput Screening (HTS) to identify compounds
that inhibit biofilm formation or cause the disintegration of an already formed biofilm using
the Salmonella Enteritidis 3934 strain. Initially, we developed a new methodology for
growing Salmonella biofilms suitable for HTS platforms. The biomass associated with
biofilm at the solid-liquid interface was quantified by staining both with resazurin and
crystal violet, to detect living cells and total biofilm mass, respectively. For a pilot project,
a subset of 1120 extracts from the Fundación MEDINA’s collection was examined to
identify molecules with antibiofilm activity. This is the first validated HTS assay of microbial
natural product extracts which allows for the detection of four types of activities which
are not mutually exclusive: inhibition of biofilm formation, detachment of the preformed
biofilm and antimicrobial activity against planktonic cells or biofilm embedded cells.
Currently, several extracts have been selected for further fractionation and purification
of the active compounds. In one of the natural extracts patulin has been identified as a
potent molecule with antimicrobial activity against both, planktonic cells and cells within
the biofilm. These findings provide a proof of concept that the developed HTS can lead to
the discovery of new natural compounds with antibiofilm activity against Salmonella and
its possible use as an alternative to antimicrobial therapies and traditional disinfectants.
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INTRODUCTION
Biofilms are defined as complex microbial communities embedded in a self-produced extracellular
polymeric matrix that attach to surfaces and are the predominant mode of microbial growth in
nature (Steenackers et al., 2012). Biofilm formation is a developmental process which starts with a
motile cell approaching and adhering reversibly to a surface (O’Toole et al., 2000). In a next step,
irreversible attachment occurs with the subsequent development of microcolonies which produce
an extracellular matrix, promoting the development of the mature three-dimensional biofilm
(O’Toole et al., 2000). During biofilm dispersal, cells undergo controlled lysis and escape from the
microbial community (O’Toole et al., 2000). Biofilms become a threatening concern since they
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might provide a reservoir of pathogenic bacteria, increasing the
risk of microbial contamination, and leading to critical problems
in terms of public health and economical lost (Shi and Zhu,
2009). They are recalcitrant, highly resistant to antimicrobials
and disinfectants and consequently are extremely difficult to
eradicate (O’Toole et al., 2000; Bridier et al., 2011). There are
two main mechanisms that contribute to such recalcitrance, (i)
the biofilm matrix might prevent the diffusion of the biocides
toward the cells and (ii) some cells within a biofilm show very
low metabolic activity (dormant cells) becoming resistant to
the action on many biocides (Otto, 2008; Lister and Horswill,
2014). It has been estimated that the minimum concentration of
biocide required to kill bacteria within a biofilm may be up to
100–1000 times higher compared to planktonic cells (Costerton
et al., 1995; Stoodley et al., 2002; Høiby et al., 2010). Since
most antimicrobials currently in use show a poor activity against
bacteria embedded in biofilms (Høiby et al., 2010), search for new
molecules with antibiofilm properties is a thrilling challenge.
During food processing, contact of food products with biofilm
contaminated surfaces is a relevant mode of transmission of
pathogens and spoiling bacteria (Chmielewski and Frank, 2003).
Adhesion of Salmonella to food surfaces was the first published
report on foodborne bacterial biofilm (Duguid et al., 1966).
Salmonella enterica serovar Enteritidis is one of the causal
agents of salmonellosis, a food-borne disease with high incidence
worldwide, affecting tens of millions of human cases, according
to WHO (Kirk et al., 2015). Every year, Salmonella spp. non-
typhoidal is estimated to cause up to 1,200,000 cases in USA, with
23,000 hospitalizations and 450 deaths (Scallan et al., 2011). The
high persistence of non-typhoidal Salmonella relies on its ability
to form biofilms (Steenackers et al., 2012).
Within this context, natural products (NPs) yielded by
bacterial, fungal, plant, and marine sources, represent a large
family of diverse chemical entities with a wide variety of
biological activities that have found multiple uses, remarkably
in human and veterinary medicine and in agriculture (Katz
and Baltz, 2016). They serve as a valuable source for novel
molecular scaffolds in drug development, and around 65% of
all approved drugs are classified as NPs or are inspired by a
NP core (Newman and Cragg, 2012). As compared to synthetic
molecules, NPs possess structural diversity and complexity, more
stereogenic centers and fewer halogen or nitrogen atoms (Chen
et al., 2015). These properties are expected to contribute to the
ability of NPs collections to provide hits even against the more
difficult screening targets (Harvey et al., 2015). In this report, we
describe the development of a robust and validated experimental
approach using a High-Throughput Screening (HTS) platform to
identify natural compounds that either can inhibit the formation
or can eliminate or disperse S. enterica preformed biofilms. S.
enterica serovar Enteritidis strain 3934, a clinical isolate capable
of forming biofilms at the air-liquid interface (pellicle) in rich
salt-free media, was selected as a model organism (Solano et al.,
1998). Although relevant pathogens form pellicle biofilm, there
are not reliable methods available to accurately quantify pellicle
biofilms formed in small cultures. Most of the studies are based
in visual inspection of the pellicle and qualitative comparison
among samples. For the purpose of evaluating the effect of a
vast number of compounds on Salmonella biofilms, a robust
and reliable methodology to quantify biofilms was needed. To
do that, the growth conditions in which S. enterica serovar
Enteritidis forms a solid-liquid interface biofilm suitable for an
easy and reliable quantification during the HTS were validated.
This approach has led us to the identification of compounds
active against biofilm formation and compounds that promote
dispersion of already existing biofilms. The experimental layout
has been successfully applied to screen 1120 natural extracts
from actinomycetes and fungi of the Fundación MEDINA’s
collection. Five of these extracts have been selected attending to
its antibiofilm activity. Amongst them, using a bioassay-guided
fractionation approach, we have identified patulin, a mycotoxin
that shows a great potential as antimicrobial agent against biofilm
embedded bacterial cells.
MATERIALS AND METHODS
Bacterial Strains and Culture Media
S. enterica serovar Enteritidis strain 3934 (Solano et al., 1998),
a clinical isolate described previously, was used for HTS
experiments. The clinical isolates of S. enterica serovar Enteritidis
HC164372.7 and S. enterica serovar TyphimuriumHC142156206
(Microbiology Laboratory at the Hospital Clinic of Barcelona,
Spain) and strain S. enterica serovar Typhimurium ATCC 14028
(obtained from the American Type Culture Collection) were used
to validate the effect of culture media on Salmonella biofilms.
Cultures of the different S. enterica strains were grown in
LB-agar (10 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract, and 15
g/l agar), CFA (10 g/l casamino acids, 1.5 g/l yeast extract, 0.4 mM
MgSO4, and 0.4 mM MgCl2; Suzuki et al., 2002) or E medium.
E minimal medium was prepared by diluting to 1X a stock of
Vogel-Bonner salts 50X (0.8 mMMgSO4, 9.5 mM citrate, 57 mM
K2HPO4, and 17 mM NaNH4HPO4; Vogel and Bonner, 1956)
with sterile Milli-Q water (Milli-Q Reference, Millipore).
HTS Assay Conditions
HTSwas performed in sterile, flat-bottomed, 96-well-polystyrene
micro-well-plates (Nunclon 1 surface; Nunc, Roskilde,
Denmark). For biofilm formation assays, each 96-well-plate
was loaded as follows: 10 µl of antibiotics, dimethyl sulfoxide
(DMSO), or extracts (2X whole broth equivalents, WBE) from
the Fundación MEDINA’s collection (Genilloud et al., 2011;
Monciardini et al., 2014; http://www.medinadiscovery.com) was
added per well using an automated Aquarius Multi-channel
Pipettor (Tecan) and a volume of 90 µl of the E minimal
medium containing the Salmonella inoculum was added using
Multidrop Combi (Thermo). The optimum inoculum per well
was∼1.4× 106 cfu/well, which corresponds to an OD612 of 0.02.
Plates were incubated for 72 h at 25◦C in static conditions inside
a plastic bag with wet cellulose paper to maintain the proper
humidity levels. For the “biofilm formation assay,” total biomass
(planktonic and biofilm) was monitored by determination of the
OD612 before and after incubation using an EnVision Multilabel
Plate Reader (PerkinElmer). Next, staining with resazurin (RSZ)
and crystal violet (CV) was performed. For “biofilm dispersal
assay,” Salmonella cells were inoculated on 96-well-microplates
as mentioned above, with the difference that no extract was
added in order to obtain a mature biofilm. After incubation
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(72 h at 25◦C), plates were washed twice with sterile Milli-Q
water, pat dried and natural extracts, antibiotics and DMSO
were loaded as stated above for the biofilm formation assay.
Plates were incubated for an additional 24 h and total biomass
was monitored by determination of the OD612, followed by the
determination of the viability by RSZ staining and of biofilm
biomass by CV staining.
Each 96-well-plate contained a set of control wells located
in the left and right columns (Figure S1). The control wells
were established as follows: (1) four wells without testing sample
(inoculum + 2% DMSO, as natural extracts contain a 20%
DMSO) were the untreated controls; (2) four wells without
inoculum (medium + 2% DMSO) were the negative controls;
and (3) eight wells correspond to the antibiotic kanamycin dose-
response curve (62–0.5 µg/ml, 1:2 serial dilutions).
RSZ Metabolic Assay
For quantitative measurement of the living cells of the
biofilm, RSZ staining, that monitors the metabolic activity, was
performed (O’Brien et al., 2000). Resazurin sodium salt (Sigma)
was prepared in Milli-Q water at a concentration of 0.02% (w/v)
and sterilized by filtration.
RSZ staining protocol was performed as described by
Monteiro et al. (2012) with minor changes. First, plates were
rinsed twice with distilled water and pat dried with paper towels.
Next, 100 µl of E minimal medium and 25 µl of RSZ 0.02%
was dispensed per well, incubated in the darkness for 1–2 h at
% inhibition =
[
100×
(
fluorescence intensity of
(
sample− negative control
)
fluorescence intensity of
(
untreated control− negative control
)
)]
− 100 (1)
37◦C in static conditions and fluorescence (excitation 570 nm,
emission 615 nm) was monitored using an EnVision Multilabel
Plate Reader.
CV Staining
For quantitative measurement of the biofilm biomass, CV
staining was performed. CV binds to negatively charged
molecules and can be used to stain and quantify total biomass
% inhibition =
[
100×
(
OD570 of
(
sample− negative control
)
OD570 of
(
untreated control− negative control
)
)]
− 100 (2)
comprising bacteria and extracellular polymeric substances (EPS)
within a biofilm (Stepanovic et al., 2000). CV staining protocol
was performed as described by Paytubi et al. (2014) with minor
% inhibition = 100×
[
1−
(
OD612 of
[(
sample Tf− sample T0
)
−
(
negative control Tf− negative control T0
)]
OD612 of
[(
untreated control Tf− untreated control T0
)
−
(
negative control Tf− negative control T0
)]
)]
(3)
modifications. Briefly, plates were rinsed twice with distilled
water and biofilms were fixed by heating at 80◦C for 30min. Next,
200 µl of a CV solution (1% w/v, prepared in Milli-Q water) was
added to each well and incubated for 15min, rinsed with water
and air-dried. Hundred microliter of acetic acid 30% (v/v) was
added to each well and shaken gently to ensure the complete
solubilization of the CV. The OD570nm of the resulting solution
was determined.
Fundación MEDINA’s Collection
For the primary screening campaign, a subset of 1120 microbial
extracts from different modules of the MEDINA NPs collection
was used. The microbial extracts were obtained from bacterial
and fungal strains (560 of each) cultivated in different nutritional
conditions and extracted with acetone (1:1) for 1 h in an orbital
shaker. Extracts were then centrifuged at 1500 × g for 15 min
and the supernatant concentrated to half of the original volume
(2XWBE) in the presence of a final concentration of 20%DMSO.
Extracts were stored at−20◦C in 96-well ABgene v-bottom plates
until needed.
Data Analysis
Extract activities were calculated automatically using the
Genedata Screener software (Genedata AG, Basel, Switzerland),
and the percentage inhibition of each sample (extract or
compound) was determined by the following equations,
depending on the type of staining protocol.
For RSZ staining, the percentage of inhibition was expressed
as a function of the percentage of fluorescence emitted by
resorufin (reduced RSZ that emits fluorescence) and was
calculated as follows,
The color of the wells was also visually recorded. A blue color
reflected the absence of metabolic activity (no biofilm or dead
cells in the biofilm). A fluorescent pink color (due to the presence
of resorufin, obtained by reduction of RSZ) reflected metabolic
activity (cells alive in the biofilm).
For CV staining, the percentage of inhibition was expressed
as a function of the percentage of OD570 and was calculated as
follows,
For total biomass, the percentage of inhibition was expressed
as a function of the percentage of OD612 and was calculated as
follows,
Where Tf is themeasurement at final time and T0 ismeasurement
at time zero.
Using the data obtained with RSZ staining, extracts were
selected when they displayed at least a 90% inhibition on biofilm
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formation assays. On the other hand, when looking at the effect of
the extracts on preformed biofilm by the biofilm dispersal assay,
a threshold of 45 and 35% inhibition was used for actinomycetes
and fungal extracts, respectively.
The Genedata Screener software was used to calculate the RZ′
and Z′ factors, which predicts the robustness of an assay (Zhang
et al., 1999).
LC-MS and Database Matching of Known
Secondary Metabolites
LC-MS analyses in the low (LR) or high resolution (HR)
mode were performed as previously described (Martín et al.,
2014; Pérez-Victoria et al., 2016). Database searching was
performed against the MEDINA proprietary database of
microbial metabolites or the Chapman & Hall Dictionary of
Natural Products (v25.1).
Bioassay-Guided Extract Fractionation
Culture broths generated were extracted by addition of a 1:1
volume of acetone. After agitation for 2 h and centrifugation, the
acetone was removed under a nitrogen stream and the remaining
solution was loaded onto an SP207ss cartridge (1.5 × 5 cm) that
was washed with water (100 ml) and eluted with methanol (40
ml) and acetone (60 ml). The combined organic eluates were
evaporated, the residue was dissolved in DMSO (400µl), and 200
µl of this volume were subjected to semipreparative HPLC on a
Gilson GX-281 apparatus equipped with a Zorbax SB C8 colum
(9.8 × 250 mm) at a flow rate of 3.6 ml/min, using a gradient of
H2O:CH3CN (5% CH3CN for 1 min, then to 100% CH3CN in
35 min, held at 100% CH3CN for 7 min and back to 5% CH3CN
in 1 min) and UV detection at 210 and 280 nm was monitored.
Eighty fractions were collected every 30 s frommin 2 to 42. These
fractions were evaporated, dissolved in 20%DMSO and subjected
to bioactivity test.
IC50, MIC, and MBEC Determination
IC50 (Motulsky and Christopoulos, 2003), MIC (Minimal
Inhibitory Concentration) (Clinical Laboratory Standards
Institute, 2012), and MBEC (Minimal Biofilm Eradication
Concentration) (Ceri et al., 1999) values were obtained from
dose-response curves as follows. The initial concentrations of the
different compounds and extracts were 1.66mg/ml for patulin, 50
mg/ml for kanamycin, 10 mg/ml for chloramphenicol, 25 mg/ml
for ciprofloxacin, and 2X WBE for extracts and the subsequent
points were obtained by 2-fold serial dilution. Serial dilutions of
the extracts were performed using 20%DMSO, tomake a 2% final
concentration of DMSO in the assay. Patulin (Fisher Scientific),
kanamycin (Sigma-Aldrich), chloramphenicol (Sigma-Aldrich),
and ciprofloxacin (Sigma-Aldrich) were disolved in ethyl acetate,
sterile Milli-Q water, ethanol, and HCl 0.1N, respectively, and
serial dilutions were done with the corresponding solvent. Once
the dilutions were performed, 10 µl of each dilution was used
for biofilm assays, following the same procedure as for the HTS
assay. All experiments were performed in duplicate.
IC50 on both, biofilm formation assay and biofilm dispersal
assay, was calculated using Graphpad Prism v5.01 software. MIC
was determined by readings of OD612, CV, and RSZ. MBEC was
determined by RSZ staining.
Cytotoxicity Assay
The cytotoxic activity of the different compounds was tested
against the hepatic cell line HepG2 (Knowles et al., 1980) in
the MTT colorimetric assay. MTT [3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] is a colorimetric assay
for measuring the activity of cellular enzymes that reduce
the tetrazolium dye, MTT, to its insoluble formazan, giving
a purple color (Patel and Patel, 2011). This assay measure
mitochondrial metabolic activity via NAD(P)H-dependent
cellular oxidoreductase enzymes and may, under defined
conditions, reflect the number of viable cells (Patel and Patel,
2011). Cells were seeded at a concentration of 1× 104 cells/well in
200 µl of Dulbecco’s Modified Eagle Medium (DMEM) (Gibco)
without phenol red and incubated at 37◦C in 5% CO2. DMEM
includes higher concentrations of amino acids than Eagle’s Basal
Medium (Gibco) so that the medium more closely approximates
the protein composition of mammalian cells. After 24 h, when
the monolayer formed, the medium was replaced with a final
volume of 200 µl of new medium with tested compounds or
controls were added to the plates. For dose-response curves, cells
were treated with eight 2-fold serial dilutions of each compound
spanning concentrations from 50 to 0.39 µM in 0.5% DMSO
final. Controls were on the first and the last columns of the plates.
On the first column, methyl methanesulfonate (MMS; Naji-Ali
et al., 1994) was included as a positive control of cytotoxicity and
DMSO as a negative control. On the last column there were four
points of doxorubicin, another positive control of cytotoxicity
(Tacar et al., 2013), with an initial concentration of 10 mM and
1:2 serial dilutions. When compounds and controls were added,
plates were incubated at 37◦C in 5% CO2 incubator for 72 h. The
sample solution in wells was flicked off and 100 µl of MTT dye
was added to each well. MTT solution was prepared at 5 mg/ml
in PBS 1X and then diluted at 0.5 mg/ml in DMEM. The plates
were gently shaken and incubated for 3 h at 37◦C in 5% CO2
incubator. The supernatant was removed and 100 µl of DMSO
100% was added. The plates were gently shaken to solubilize
the formed formazan. The absorbance was measured using a
multireader VictorTMWallac spectrofluorometer (PerkinElmer)
at a wavelength of 570 nm.
RESULTS AND DISCUSSION
Salmonella Biofilm Assay Setup
Römling and Rohde (1999) showed that S. Typhimurium ATCC
14028, when grown in a minimal medium, forms a so called
“bottom” biofilm instead of a pellicle at the air-liquid interface.
This type of biofilm is characterized by an equal distribution of
cells on the solid-liquid interface (wall of the tube). Therefore,
we tested whether strain 3934 was able to form bottom biofilms
on polystyrene surfaces when grown in E minimal medium
and standing culture. Twenty-four-well-plates were used for that
purpose, and the Salmonella 3934 strain was inoculated in 1
ml of either CFA (rich medium) or E minimal medium. As
shown in Figure 1, after 72 h incubation at 25◦C, strain 3934
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FIGURE 1 | Different types of biofilms formed by S. Enteritidis 3934
when grown in 24-well-polystyrene plate in CFA (pellicle) or E medium
(bottom) stained with CV after 72h incubation at 25◦C. Negative controls
are shown.
forms pellicle biofilms in rich media which is detected as a ring
formed on the solid surface exposed to the air-liquid interphase.
However, when grown in minimal medium, no pellicle biofilm
was observed and a bottom biofilm was clearly detected. Bottom
biofilm is easier to detect and more reliable to quantify by
staining methods than pellicle biofilm. Remarkably, the observed
phenomenon is not specific to S. Enteritidis 3934. As shown
in Figure S2, the effect has also been observed on other S.
enterica strains from serovars Typhimurium and Enteritidis. It
is intriguing to note that alterations in the culture medium
composition cause such relevant changes in the way a biofilm is
formed by Salmonella (bottom or pellicle). Further studies will
be required to characterize the effect of the media on biofilm
formation.
Salmonella Biofilm Assay Design
Optimization
Once the E minimal medium was selected to be used for
the biofilm formation, a standardized protocol to grow robust
biofilm was defined.
The inoculum was prepared from fresh Salmonella 3934
grown O/N on LB-agar plates at 37◦C. A cell suspension was
prepared and diluted in Emedium to a final OD612 of 0.02, which
results in ∼1.4 × 106 cfu/well. To check the effect of a given
extract on biofilm formation, 90 µl of this suspension was mixed
with 10 µl of the extract for 72 h at 25◦C. Since the extracts
were at a concentration of 2X WBE, the resulting concentration
assayed in all cases was at 1/5X WBE. Cultures were incubated
at 25◦C for 72 h, until a thick bottom biofilm was detected.
Additionally, to analyse the activity of an extract on a pre-existing
biofilm, first 100 µl of the suspension was inoculated per well
and allowed to form a mature biofilm. After 72 h incubation at
25◦C, wells were rinsed and 90 µl of fresh media and 10 µl of
the extracts were added, as above. The incubation was extended
for 24 h incubation at 25◦C (see Section Materials and Methods).
For untreated controls, DMSO was added to fresh media instead
of extracts.
Next, antibiotic sensitivity, DMSO tolerance and the staining
procedures used to monitor biofilm mass were optimized. Three
technical replicas and three biological replicas were used for all
validation assays.
The optimization of the experiment, the reproducibility
and the sensitivity of our method to detect deleterious effect
on different stages of biofilm development, were evaluated
by performing susceptibility dose curves (from 1 mg/ml
to 0.5 µg/ml) with two different antibacterial compounds:
kanamycin, a bactericidal antibiotic (Scholar and Pratt, 2000),
and chloramphenicol, a bacteriostatic antibiotic (Scholar and
Pratt, 2000). The results showed that the methodology used
is appropriate to evaluate the effect of compounds that alter
biofilm, both during formation of the biofilm or by dispersing
preformed biofilms. The MIC was 62 µg/ml for kanamycin
and 4 µg/ml for chloramphenicol (Figure 2A), whereas the
MBEC for both antibiotics was above 1 mg/ml (Figure 2B).
Thus, the MBEC/MIC ratios were higher than 15- and 250-
fold for kanamycin and chloramphenicol, respectively. These
results are in agreement with the estimated concentration of a
biocide required to eliminate biofilm which are up to 100–1000
times higher compared to the concentration necessary to kill
planktonic cells (Costerton et al., 1995; Stoodley et al., 2002;
Høiby et al., 2010). A significant difference in antimicrobial
susceptibility has also been described between the planktonic and
biofilm forms of S. enterica strains isolated from clinical cases
with gastroenteritis, with the biofilm forms showing increased
resistance rates (Papavasileiou et al., 2010). The spectrum of
concentrations of both antibiotics used in the assay spans
from 1000 to 0.5 µg/ml. Within this range, kanamycin showed
to provide a clearer increase in its inhibitory effect than
chloramphenicol. For that reason, kanamycin was chosen as a
control for the HTS assay.
As the HTS was going to be performed with extracts
that contained a 20% DMSO, which would lead to a final
concentration of 2% in the culture, the effect of DMSO on
Salmonella 3934 biofilms was also tested. The bacteria were
grown in the presence of 12 different concentrations of DMSO
ranging from 10 to 0.005%. The results showed that at the
working concentration of 2%, DMSO displayed low impact on
biofilm formation and no effect on dispersing preformed biofilm
(data not shown).
For quantitative measurement of the biofilm biomass, CV
staining was performed. CV assay is cheap, straightforward and
has been extensively used for the quantification of biofilms
formed by a broad range of microorganisms (Peeters et al., 2008).
The OD570 signal achieved for the untreated control stained with
CV was 0.65 ± 0.07 and the ratio of the signal detected between
the untreated control and the negative control was∼7, providing
a wide window between controls and thus, granting a good
biofilm mass quantification method for our assays. Although
CV is probably one of the dyes most used for quantifying
biofilm it is inadequate to assess viability of biofilm cells because
matrix and both living and dead cells are stained by CV. An
alternative methodology to monitor bacterial biofilm employing
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FIGURE 2 | Susceptibility dose curves with 2-fold serial dilutions of
kanamycin and chloramphenicol. (A) Biofilm formation assays allow the
determination of the MIC of the antibiotics and (B) dispersal of preformed
biofilm assays allow the determination of the MBEC. Top panels show RSZ
and bottom panels show CV staining. Untreated controls are 12 replicas of the
bacterial culture without the addition of antibiotic.
RSZ was also tested. RSZ is a non-toxic, water-soluble blue dye
which is reduced by electron transfer reactions associated with
respiration producing resorufin, a water-soluble pink product
highly fluorescent (Twigg, 1945; O’Brien et al., 2000). RSZ has
been used to assess viability and bacterial contamination, to test
for antimicrobial activity, and as an indicator of bacterial cell
numbers (Shiloh et al., 1997; Sarker et al., 2007). Over the last few
years, several assays for biofilm quantification in microtiter plates
have been described showing RSZ as one of the best alternatives
for microbial biofilm quantification (Peeters et al., 2008; Mariscal
et al., 2009). The fluorescence values achieved with RSZ for
untreated controls were 9164 ± 573, showing a ratio between
untreated controls and negative controls of 9, which also makes
it an appropriate staining method. Quantification of biofilms by
both methods, CV and RSZ, plus the determination of the OD612
of each well, would provide information of the specific activity of
a given extract.
Since we were interested in collecting data from both staining
methods, we tested whether there were significant differences
between staining the biofilms with CV and staining first with
RSZ and then with CV. Indeed, as shown by Skogman et al.
(2012), no effect of the RSZ staining could be detected in
the amount of biomass stained by CV in the same assay
plate when compared to the staining performed in separate
plates, as no statistical significance was detected between both
staining procedures (p = 0.16). The OD570 signal achieved
for untreated biofilms stained directly with CV was 0.65 ±
0.07, whereas the signal measured for the CV staining after
staining with RSZ was 0.62 ± 0.13. Moreover, the ratio of
the signal detected between the untreated control cells and the
negative control was very similar to that observed for the CV
staining, thus keeping the suitability of the assay. Therefore, to
save aliquots of microbial extracts, consumables and reagents,
we decided to perform the assays following the second
strategy.
Screening Campaigns and Hit
Identification
After optimization of the experimental setup, a subset of 1120
microbial extracts (560 derived from actinomycetes and 560
from fungi) from the Fundación MEDINA’s collection were
examined to identify molecules with antibiofilm activity by
inhibiting biofilm formation, promoting dispersal of mature
biofilms or both activities. Calculated parameters during the
HTS resulted in Z′ factors between 0.79 and 0.97 and RZ′
factors comprised between 0.86 and 0.98, indicating the
high robustness and reproducibility of the HTS assay. From
the primary screening, different degrees of inhibition were
detected.
Using the data obtained with RSZ quantification, extracts were
selected when they displayed at least a 90% inhibition on the
biofilm formation assay. Using this criterion 32 extracts were
selected, 11 from actinomycetes, and 20 from fungi. On the other
hand, when looking at the effect of the extracts on the biofilm
dispersal assay, lower levels of metabolic activity inhibition were
detected. In this case, a threshold of 45 and 35% inhibition
was used for actinomycetes and fungal extracts, respectively.
Consequently, 14 extracts from actinomycetes and eight from
fungi were selected. Remarkably, three of the above mentioned
extracts showed effects on both formation and dispersal of
the biofilm (Table 1). Altogether, 50 extracts from a total of
1120 assayed (4.46%) were initially identified as anti-Salmonella
biofilm hits for further studies.
A cherry-picking campaign was carried out to confirm the
activity and reproducibility of the effect on biofilms of the
natural extracts and confirmed 40 of the initial hits (Table 1 and
Table S1).
Additionally, cytotoxicity of the extracts was tested using the
hepatic cell line HepG2. A total of 19 extracts (Table S1) was
found to inhibit <30% growth of HepG2 cells when tested at
1/40XWBE final concentration for 72 h.
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TABLE 1 | Number of extracts identified as hits at different stages of the
screening process.
Primary
HTS
Cherry-
picking
<30% HepG2
Cell Death
Prioritized for
refermentation and
activity confirmation
Actinomycetes 24 20 11 3
F 10 8 5 2 (#33 and #35)
D 13 11 5
F+D 1 1 1 1 (#31)
Fungi 26 20 8 2
F 18 15 6
D 6 3 2 1 (#7)
F+D 2 2 – 1 (#25)
Total 50 40 19 5
F, Formation; D, Dispersal; F+D, Formation and Dispersal.
Small-Scale Regrowths
As described by others (Sandberg et al., 2008, 2009; Skogman
et al., 2012; Fallarero et al., 2013; Manner et al., 2013), by
combining the data on biofilm quantification by both RSZ
and CV staining methods and the value of OD612 of the
culture, more specific information on the activity of the extracts
can be obtained. As shown in Table 2, we define four types
of activities amongst the extracts, which were not mutually
exclusive, that is: (1) inhibition of biofilm formation, (2)
antimicrobial activity of cells in suspension, (3) antimicrobial
activity of cells that are part of the biofilm, and (4) dispersal of the
biofilm.
At this stage, three extracts from bacterial cultures (#31,
#33, and #35) and one extract from fungal cultures (#7)—
identified as containing potentially novel active components—
were prioritized. Two of them were able to inhibit biofilm
formation (#33 and #35); one extract had antimicrobial activity
against cells in suspension and cells within a biofilm (#31);
and extract #7 was able to disperse biofilm. Additionally, we
also prioritized extract #25, which in spite of showing a clear
cytotoxicity also retained a very strong antimicrobial effect
on both planktonic and sessile cells (Table 3). It is worth
mentioning that natural extracts may contain hundreds of
different compounds. Thus, the cytotoxic activity of extract
#25 on HepG2 cells might be caused by compounds different
to those showing an antibiofilm effect. The percentage of
inhibition of the biofilm at the different points of the screening
for the four extracts prioritized plus extract #25 is shown in
Table 3, as well as two extracts with no antibiofilm activity for
reference.
A database search, which matches UV-LC-MS data of the
metabolites in the active extracts to UV-LC-MS data of known
metabolites, did not show any known or conclusive metabolite,
suggesting that they were likely to contain novel potentially active
components. Thus, the same producing bacterial and fungal
cultures were regrown in 10 ml and 100 or 150 ml volumes
(for fungal and bacterial cultures, respectively) in the same
production conditions and the antibiofilm activity of the newly
TABLE 2 | Antibiofilm activities detected at the HTS.
OD612 Resazurin Crystal violet
Untreated +++ +++ +++
Formation 1 +++ + +
2 + + +
Dispersal 3 n.d. + +++
4 n.d. + +
n.d., not determined.
+ and +++ refers to low and high levels of the specified parameter, respectively.
generated crude extracts was assessed. The activity of the five
natural extracts was confirmed (data not shown).
Dose-Response Experiments
To assess the potency of the five extracts selected, we performed
dose-response experiments with the small-scale regrowth
extracts. The extracts were tested in a 12-point dose-response
assay, being the first point the initial dilution previously
described for each assay (1/5X WBE, final concentration)
followed by the 11 subsequent 2-fold serial dilutions
(Figure 3).
Dose-response assays performed confirmed the activity of the
extracts tested inhibiting biofilm formation (Figures 3A,C). The
most potent extract was #25, which showed an IC50 between 3
and 10 times lower than the rest of the extracts previously proved
to retain this activity (#31, #33, and #35). This extract maintains
an inhibition percentage of 90% up to the 64-fold dilution of the
original extract, whereas the other extracts dropped their activity
after the 2-fold (#35) or the 8-fold (#31 and #33) dilution of the
initial extract.
When extracts #7, #25, and #31 were tested for their
activity dispersing preformed biofilm (Figures 3B,C), we could
observe that much higher concentrations were required to detect
antibiofilm activity. Moreover, we were only able to calculate the
IC50 for extract #25, since the other two extracts did not reach
a 100% dispersal of the preformed biofilm. Extract #25 showed
an increase of the IC50 of ∼8-fold, compared to its inhibitory
activity on biofilm formation. However, our data suggest that
extract #25 contains a very potent compound that can efficiently
affect biofilm cells compared to other antibiotics. As shown in
this report for kanamycin and chloramphenicol and in other
studies (Costerton et al., 1995; Stoodley et al., 2002; Høiby
et al., 2010), antibiotics are largely inefficient against bacteria
grown in biofilms. Notoriously, the IC50 for this extract was one
dilution higher when stained with CV than with RSZ, indicating a
reduction of viability of the cells embedded in the biofilm rather
than a dispersal of the total biofilm biomass. Although extract
#7 was chosen for its specific activity against preformed biofilms,
in contrast to extract #25, at the maximum concentration it was
only able to reduce a 40% of the living cells within the biofilm.
Similarly to extract #7, it was not possible to calculate the IC50 of
extract #31, since the maximum activity reached was much lower
than 100%.
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FIGURE 3 | Dose-response curves of the selected extracts identified
for its activity inhibiting biofilm formation (#25, #35, #33, and #31) or its
activity dispersing preformed biofilms (#7, #25, and #31). Dose-response
curves of the indicated extracts on biofilm formation assays (A) or on biofilm
dispersal assays (B). The inhibitory activity of each extract was determined by
RSZ staining. Mean and standard error of mean of two independent
experiments is shown. (C) IC50-values obtained after staining with RSZ and
CV are shown in whole broth equivalents of the selected natural extracts.
Interestingly, the dose-response curve displayed by extract #25
on biofilm dispersal shows an increase in the metabolic activity
at concentrations immediately below the IC50. The U-shaped
dose-response observed is known as hormesis, a phenomenon
characterized by a low dose stimulation and high dose inhibition,
and it has been extensively described for antibiotics (Davies et al.,
2006). The behavior observed by extract #25 was detected by
RSZ staining method but not by CV staining (data not shown),
suggesting that, at sublethal concentrations, active compounds
contained in this extract cause a bacterial stress that is associated
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to the high metabolic activity rather than an increase of the total
biomass of the biofilm.
Fractionation of the Small-Scale
Regrowths, De-Replication of Active
Fractions, and Dose-Response
Experiments
To identify the antimicrobial compound present in extract
#25, extracts from 10 to 100 ml cultures were fractionated
as indicated in Materials and Methods Section. Two fractions
were shown to retain the same activity as the original natural
extract. A database search performed using UV-LC-MS data,
identified patulin in the two active fractions of extract #25.
We were not able to identify patulin in whole extract #25,
indicating the high complexity of this extract. Patulin is a
fungal mycotoxin produced by certain molds of the genera
Penicillium, Aspergillus and Byssochlamys growing on a variety
of foods including fruit, grains, and cheese (Sommer et al., 1974;
U.S. Food and Drug Administration). Patulin, also known as
clavacin, claviformin, expansin, mycoin C, and penicidin, shows
antibiotic activity against Gram-negative and Gram-positive
bacteria (reviewed in Hopkins, 1943; Florey et al., 1949).
Although it has been reported that patulin shows cytotoxic
activity against some cell lines (Puel et al., 2010; Song et al., 2014;
Figure S3), according to the International Agency for Research
on Cancer (IARC, http://www.iarc.fr), patulin is classified in
the group 3 as “not classifiable as to its carcinogenicity
to humans” (International Agency of Research on Cancer,
1986).
Based on the commercial availability of patulin, we decided to
test whether this compound was the responsible of the inhibitory
activity on Salmonella biofilms performing dose-response
assays. As a control, we used kanamycin, a broad-spectrum
antibiotic against many Gram-negative and Gram-positive
bacteria (Takeuchi et al., 1957), and ciprofloxacin, a broad-
spectrum second generation fluoroquinolone (King et al., 2000)
and the most often used antibiotic against Salmonella non-
typhoidal infections (Gilbert et al., 2016).
As shown in Figures 4A,C, patulin, kanamycin, and
ciprofloxacin prevented biofilm formation with a MIC of 1.3, 62,
and 0.3 µg/ml, respectively, as monitored by both RSZ (living
cells) and CV (biomass) determination. At concentrations of the
compounds higher than the MIC, we also observed a decrease
of the OD612, clearly indicating that all the tested compounds
kill the planktonic cells, thus avoiding biofilm formation. This
indicates an antimicrobial behavior of the compounds tested
rather than an inhibition of biofilm formation. According to that
observation and in spite of the small differences between the
data obtained from both staining methods, similar results from
both assays were seen. The calculated IC50 and MIC indicate that
ciprofloxacin is the most potent antibiotic of the assay, with an
activity between 5- and 14-fold higher than patulin, respectively
(Figure 4). Patulin shows higher antimicrobial activity than
kanamycin since it showed a MIC of 1.3 µg/ml, which is in
the order of 50-fold more potent than kanamycin. Also, the
ratios between IC50 of both compounds were similar to the
ratios shown for the MIC. It is noteworthy mentioning that,
isolated compounds with MICs < 10 µg/ml are considered very
interesting as antimicrobial agents (Ríos and Recio, 2005).
When looking at the activities of the compounds tested on
preformed biofilms, we observed that patulin treatment produce
a 90% decrease of RSZ staining (cell viability) but a 30% decrease
of CV staining (cell biomass). This effect can be explained by the
fact that RSZ only monitors living bacteria and the dead cells that
are stained with CV are not taken into account (Skogman et al.,
2012). Thus, patulin activity on preformed biofilms is likely to be
through killing bacteria embedded into the biofilm which leads
to a partial dispersion of the biofilm.
Moreover, when assaying the dose-response curve of
patulin on biofilm dispersal assays (Figure 4B) we detected a
phenomenon similar to that observed in extract #25. Patulin
causes an eustress- a beneficial stress followed by an inhibitory
activity—at sublethal concentrations, that is at concentrations
between 5.2 and 1.3 µg/ml. Therefore, we may conclude that
the hormesis event observed in extract #25 was likely to be
carried out by patulin. It is noteworthy mentioning that patulin
was found to enhance biofilm formation in P. aeruginosa
in a concentration dependent manner up to the maximal
concentration of 25 µM (Liaqat et al., 2010) which corresponds
to 3.8 µg/ml. They also observed that patulin prolonged the
lag phase in P. aeruginosa at concentrations >10 µM (1.54
µg/ml). More recently, the effect of patulin was tested on
Halomonas pacifica and Marinobacter hydrocarbonoclasticus,
two halophilic marine micro-organism involved in biofouling
processes (Liaqat et al., 2014). Biofilm formation on H. pacifica
was enhanced with increasing patulin concentration up to 10
µM and then decreased significantly with maximum inhibition
at 25 µM concentration. This behavior corresponds to the
eustress caused by patulin that we also observe. No significant
effect of patulin was observed on M. hydrocarbonoclasticus.
We would like to highlight that the concentrations used in
both works are in the range of concentrations observed in this
study that cause the eustress effect on Salmonella. The fact that
patulin shows an enhancing effect on P. aeruginosa biofilms or
no effect on M. hydrocarbonoclasticus biofilms might be due
to the concentrations used in the assay, which are probably
in the eustress zone or below the sublethal concentration,
respectively. Interestingly, patulin has been described as a
biologically active quorum-sensing inhibitory (QSI) compound
in P. aeruginosa (Rasmussen et al., 2005). The target of
patulin in Salmonella remains unknown and deserves further
research.
Remarkably, the comparison of the metabolic activities (RSZ
staining) of the Salmonella preformed biofilms treated with
the tested compounds, exhibited patulin as the most potent
antimicrobial assayed. Patulin is more than 15-fold stronger
than ciprofloxacin on killing biofilm cells, since 166 µg/ml
were needed to obtain a 90% reduction, whereas 27–19%
was the maximum inhibitory activity reached for ciprofloxacin
at a concentration of 4.8 µg/ml. At higher concentrations
than 4.8 µg/ml, the inhibitory activity of ciprofloxacin shows
a slight decrease. The reduction in bactericidal activity with
concentrations of antibiotics above a critical level has been
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FIGURE 4 | Dose-response curves of patulin, kanamycin, and ciprofloxacin. The inhibitory activity in biofilm formation assay (A) or in biofilm dispersal assay (B)
was determined by RSZ (•) or CV () staining. Mean and standard error of mean of two independent experiments is shown. (C) IC50, MIC, and MBEC-values (µg/ml)
for patulin and the two broad-spectrum antibiotics used are shown.
described as “paradoxical effect” and it is well-documented
for ciprofloxacin and other quinolones (Dörr et al., 2009;
Malik et al., 2009). Moreover, in the case of ciprofloxacin, the
reduction of preformed biofilm detected was higher when the
biofilm was stained with CV. In this case, the maximal activity
detected with CV after treatment with ciprofloxacin starts at
2.4 µg/ml and from this point, the inhibitory activity hit a
plateau.
In summary, the HTS designed reveals to be a powerful tool
for the identification of novel NPs with antimicrobial activity
on Salmonella biofilms. While similar platforms have already
been described to identify different types of antimicrobial activity
of a given compound (Sandberg et al., 2008, 2009; Skogman
et al., 2012; Fallarero et al., 2013; Manner et al., 2013), this
approach identifies compounds that inhibit biofilms of the
relevant pathogen Salmonella. Moreover, it must be pointed up
that the developed HTS uses a collection of NPs to search for
new antibiofilm compounds. The pilot screening used to validate
the methodology, drove us to the identification of patulin as a
molecule that efficiently kills Salmonella cells within a biofilm.
Indeed, the biocide effect of patulin on biofilm embedded bacteria
is much more powerful than the observed for ciprofloxacin, the
most common antibiotic used for treatment of salmonellosis.
Patulin cytotoxicity against some cell lines has been reported
(Puel et al., 2010; Song et al., 2014) and this might limit its use
in clinical practice. Although further studies will be required
to determine its possible use for biomedical purposes, patulin
has a great potential as disinfectant. We would like to highlight
that HTS has been performed at 25◦C, temperature that mimics
environmental conditions rather than in-host environment. In
this report, we describe and validate an HTS assay to identify
new and effective antibiofilm molecules. This approach can
potentially provide, as exemplified by the finding of patulin
during the pilot screening, tools to reduce costs of disinfection
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of industrial facilities and to improve the food quality, and safety
of the final products.
CONCLUSIONS
We have identified and validated the growth conditions for S.
Enteritidis to grow forming a bottom biofilm. These findings
were central to establish a robust, reliable, and comprehensive
HTS platform for the identification of potentially novel NP-
based drug leads which either can inhibit the formation or can
eliminate or disperse preformed biofilms of Salmonella. This
platform has been used in a pilot project to screen 1120 microbial
extracts and has confirmed 40 extracts as having potential
novel antibiofilm metabolites. Four of them are currently
under study for the identification of novel hit components
and we hope they can deliver new molecules active against
Salmonella biofilms. The pilot screening performed opens the
possibility to perform screenings with a much larger collection
of NPs. This approach meets the demanding requirements of
HTS drug discovery, and also it has been validated with the
identification of patulin as component of one of the bioactive
extracts.
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Figure S1 | Set of control wells used in the HTS assays, located in the left
(negative and untreated controls), and right (kanamycin dose-response
curve) columns of the 96-well-plates.
Figure S2 | Different types of biofilms formed by S. Enteritidis 3934 and
164372.7 and S. Typhimurium HC142156206, SV5015, and ATCC 14028.
Cells were grown in 24-well-polystyrene plate in E medium (bottom biofilm) or CFA
(pellicle) and stained with CV after 72 h incubation at 25◦C. Negative controls for
each media are shown.
Figure S3 | Dose-response curve of the cytotoxic activity of patulin on
hepatic cell line HepG2 cells after 72 h treatment. The IC50-value obtained
was 0.46 µM.
Table S1 | Activities shown by the 40 pre-selected extracts confirmed
by cherrypicking. The data indicates the percentage of inhibition of biofilm
formation determined by resazurin (viability) and OD612 measures (total
biomass), and the percentage of dispersal of preformed biofilm determined
by resazurin (viability) and CV staining (biofilm biomass), in the screening
and cherry-picking campaigns. Day 1 and 2 refers to the data obtained
independently in 2 different days. In red, cytotoxicity levels on HepG2 cells
higher than 30% are shown.
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